Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.

guest :: login DZNEPUB
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help

Home > Publications Database > Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease. > Access to Fulltext

Information
Files

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease. - DZNE-2025-01078

Main document file(s):

Similar records

DZNEPUB :: :: :: ::
Powered by v1.1.7 |
Maintained by

Impressum | Data Privacy Policy